Cetirizine Hydrochloride Tablet, Coated
Product Images NDC 62207-764

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cetirizine Hydrochloride (NDC 62207-764). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules India Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cet-label-30 (Cet Label 30)

This text provides information about Cetirizine Hydrochloride Tablets USP containing 10 mg of Cetirizine Hydrochloride. The batch number, number of units, manufacturing date, expiration date, manufacturing license number, and NDC number are also listed. It includes storage instructions to keep the tablets between 20°C to 25°C. The tablets are specified for repacking only. The manufacturing company is Granules India Limited located in Telangana, India. The text also mentions the country of origin as India and provides an FG code.*

FDA Label Image

Cet-label-88 (Cet Label 88)

This is information for Cetirizine Hydrochloride Tablets USP, each containing 10mg of Cetitizine Hydrochloride. The batch consists of 100,000 units with specific manufacturing and expiration dates. It should be stored between 20°C to 25°C. The product is for repacking only. The manufacturer is Granules India Limited located in Telangana, India. Please refer to the provided FG Code for further identification.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.